高尿酸血症的防治策略研究进展

胡欣瑜; 张楠; 董鲜祥; 段为钢; 云宇

高尿酸血症的防治策略研究进展

1. 昆明医科大学基础医学院药理学系
2. 云南中医学院中医药学分子生物学重点实验室

基金项目:

基金：国家自然科学基金资助项目 (81860162); 云南省教育厅科学研究基金资助项目 (2018JS153);

计量
- 文章访问数: 2395
- HTML全文浏览量: 841
- PDF下载量: 327
- 被引次数: 0
出版历程
- 收稿日期: 2018-11-19

Update of Treatment for Lowering Serum Urate

Funds:

基金：国家自然科学基金资助项目 (81860162); 云南省教育厅科学研究基金资助项目 (2018JS153);

摘要

摘要: 高尿酸血症是多种疾病的生化基础。降低血尿酸水平可有效防止痛风、肾功能障碍和多种心血管疾病。近年来, 高尿酸血症的防治研究不断取得新成果, 为此, 先简要概述尿酸的来源与去路, 从抑制尿酸合成、促进尿酸排泄和促进尿酸降解方面进行了梳理, 最后提出经肠道局部治疗可能是以后降尿酸的发展方向。
- 高尿酸血症 /
- 黄嘌呤氧化酶抑制剂 /
- 促尿酸排泄药 /
- 碱化尿液 /
- 尿酸酶
Abstract: Hyperuricemia is a foundation of multiple diseases, and lowering serum uric acid is able to effectively prevent and treat the diseases such as gout, renal dysfunction and cardiovascular diseases. Recently, new achievements in study on hyperuricemia treatment and prevention were emerged, which needs to be summed up.At first, the present article briefly reviewed the synthesis and elimination of uric acid, and grouped the ways of prevention and treatment into three strategies: inhibiting synthesis, enhancing excretion, and promoting degradation. In the end, the article put forward that future strategy should focus on intestinal tract to lower serum uric acid by local rather than systematic administration.
- Herperuricemia /
- Xanthine oxidase inhibitor /
- Uricosurics /
- Urine alkalization /
- Urate oxidase

HTML全文

参考文献(26)

[1]	[1]ZHU C, CUI R, GAO M, et al. The Associations of serum uric acid with obesity-related acanthosis nigricans and related metabolic indices[J].Int J Endocrinol, 2017, 2017:5438157.
[2]	[2]ORTH-GOMER K, AHLBOM A. Impact of psychological stress on ischemic heart disease when controlling for conventional risk indicators[J].J Human Stress, 1980, 6 (1) :7-15.
[3]	[3]BESLON V, MOREAU P, MARUANI A, et al. Effects of discontinuation of urate-lowering therapy:A systematic review[J].J Gen Intern Med, 2018, 33 (3) :358-366.
[4] 赵百学, 陈建华.灵长类尿酸酶假基因化机制及其与灵长类进化关系研究进展[J].中国医药生物技术, 2014, 9 (5) :361-364.
[5]	[5]YUN Y, YIN H, GAO Z, et al. Intestinal tract is an important organ for lowering serum uric acid in rats[J].PLo S One, 2017, 12 (12) :e0190194.
[6]	[6]BASSEVILLE A, BATES S E.Gout, genetics and ABC transporters[J].F1000 Biol Rep, 2011, 3:23.
[7]陆海波, 鲁传华.高尿酸血症治疗药物黄嘌呤氧化酶抑制剂的研究进展[J].安徽医药, 2016, 20 (4) :226-630.
[8]周启蒙;杜冠华.治疗高尿酸血症相关药物研究进展[J].中国新药杂志, 2016, 25 (18) :2129-2135.
[9]	[9]SMYTH J F, PAINE R M, JACKMAN A L, et al. The clinical pharmacology of the adenosine deaminase inhibitor2'-deoxycoformycin[J].Cancer Chemother Pharmacol, 1980, 5 (2) :93-101.
[10]	[10]SPIERS A S, RUCKDESCHEL J C., HORTON J.Effectiveness of pentostatin (2'-deoxycoformycin) in refractory lymphoid neoplasms[J].Scand J Haematol, 1984, 32 (2) :130-134.
[11]	[11]ENOMOTO A, TAKEDA M, SHIMODA M, et al. Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors[J].J Pharmacol Exp Ther[J].2002, 301 (3) :797-802.
[12]	[12]SATO M, WAKAYAMA T, MAMADA H, et al. Identification and functional characterization of uric acid transporter Urat1 (Slc22a12) in rats[J].Biochim Biophys Acta, 2011, 1808 (6) :1441-1447.
[13]	[13]PASCART T, RICHETTE P. Current and future therapies for gout[J].Expert Opin Pharmacother, 2017, 18 (12) :1201-1211.
[14]	[14]SANCHEZ N M, ZHENG-LIN B, VALIO R L, et al.Lesinurad:what the nephrologist should know[J].Clin Kidney J, 2017, 10 (5) :679-687.
[15]	[15]LIEBMAN S E, TAYLOR J G, BUSHINSKY D A. Uric acid nephrolithiasis[J].Curr Rheumatol Rep, 2007, 9 (3) :251-257.
[16]云宇, 李月, 杨榕, 等.氨丁三醇在体外促尿酸溶解的作用[J].华西药学杂志, 2018, 33 (1) :L31-47.
[17]段为钢, 云宇, 殷华, 等.一种氨丁三醇有机酸盐及其制备方法和应用:中国201611220156.6[P]. 2016-12-16.
[18]	[18]MA Z, LONG L H, LIU J, et al. Montmorillonite adsorbs uric acid and increases the excretion of uric acid from the intestinal tract in mice[J]. J Pharm Pharmacol, 2009, 61 (11) :1499-1686.
[19]	[19]NIU Y, LIU J, LIU H Y, et al. Hypouricaemic action of mangiferin results from metabolite norathyriol via inhibiting xanthine oxidase activity[J].Pharm Biol, 2016, 54 (9) :1680-1686.
[20]	[20]JEON Y W, KWAK D H, PARK S S, et al. Effectiveness of single-dose rasburicase in patients with lymphoid malignancies at a high risk for tumor lysis syndrome[J].Clin Lymphoma Myeloma Leuk, 2017, 17 (9) :595-603.
[21]	[21]BALDO B A. Enzymes approved for human therapy:indications, mechanisms and adverse effects[J].Bio Drugs, 2015, 29 (1) :31-55.
[22]傅毅.高尿酸血症治疗药拉布立酶 (rasburicase) [J].国外医药 (合成药生化药制剂分册) , 2002, 23 (6) :383-384.
[23]王成君.新型抗痛风药物——Pegloticase[J].医药导报, 2012, 31 (9) :1188-1189.
[24]段为钢, 云宇, 殷华, 等.一种口服降尿酸药物的制备与应用:中国, CN106902349A[P]. 2017-06-30.
[25]	[25]LI M, YANG D, MEI L, et al. Screening and characterization of purine nucleoside degrading lactic acid bacteria isolated from Chinese sauerkraut and evaluation of the serum uric acid lowering effect in hyperuricemic rats[J].PLo S One, 2014, 9 (9) :e105577.
[26]赵百学;陈建华.灵长类尿酸酶假基因化机制及其与灵长类进化关系研究进展[J].中国医药生物技术, 2014, 9 (5) :361-364.

相关文章(20)

[1]	伍蓉霜, 彭江丽, 陈永刚, 陈洁, 马国伟, 李先蕊, 李谢, 余春红. SLC2A9基因单核苷酸多态性与吡嗪酰胺致高尿酸血症易感性关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230409
[2]	李丹, 万绪莲, 李律宇, 云宇, 罗光云, 刘韦兵, 林公府, 李宁, 黎勇坤, 段为钢. 尿酸酶缺失大鼠肠道菌群的变化, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230205
[3]	曹渊卿, 自翔宇, 朱燕昆, 袁宝红. 减重术后早期血尿酸波动的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220924
[4]	秦婉, 綦雅琳, 杲银芳, 范楠, 云宇, 段为钢. 聚乙二醇4000对Kunming-DY大鼠的降尿酸作用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220801
[5]	杨萍芬, 林华, 高丽辉, 李玲, 陈梦威, 杨娟, 王歌, 牛艳芬. 芒果苷元对尿酸性肾病大鼠尿酸排泄指标的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210633
[6]	李东云, 冮顺奎, 李捷, 张明星, 李雷. ABCG2、SLC2A9、SLC17A3和 PRKG2基因单核苷酸位点多态性与哈尼族人群痛风的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210320
[7]	张楠, 胡欣瑜, 董鲜祥, 段为钢, 云宇. 高尿酸血症动物模型的研究进展, 昆明医科大学学报.
[8]	常巍, 张雪辉, 汪洋, 王琦, 王松梅, 徐芳. 云南某农村高尿酸血症与血脂异常的相关性分析, 昆明医科大学学报.
[9]	冯国华, 林华, 普菁莹, 高丽辉, 李玲, 牛艳芬. 3,5,2’,4’-四羟基查尔酮对大鼠尿酸及PC12细胞嘌呤代谢酶的影响, 昆明医科大学学报.
[10]	常颂桔. 苯溴马隆对高尿酸血症老年高血压合并糖尿病患者降尿酸的临床疗效与安全性, 昆明医科大学学报.
[11]	郭培宇. 改良标准化疗方案治疗脊柱结核的疗效分析, 昆明医科大学学报.
[12]	王洪雄. 降尿酸对老年高血压合并糖尿病的高尿酸患者血糖的影响, 昆明医科大学学报.
[13]	张红. 外周血红细胞和血红蛋白因素与高原地区高尿酸血症患者相关性分析, 昆明医科大学学报.
[14]	梅雪. 年龄、性别因素对高原地区高尿酸血症的相关性分析, 昆明医科大学学报.
[15]	王国梁. 高尿酸血症与高脂血症的相关分析, 昆明医科大学学报.
[16]	黄文莉. 高原地区高尿酸血症与血清肌酐关系的临床研究, 昆明医科大学学报.
[17]	和学忠. 云南怒江州傈僳族高尿酸血症伴发高脂血症、高糖血症人群状况分析, 昆明医科大学学报.
[18]	谷万港. 基于结构的HIV-1蛋白酶抑制剂的虚拟筛选, 昆明医科大学学报.
[19]	李玲. 促尿酸排泄药物的研究现状及展望, 昆明医科大学学报.
[20]	常颂桔. 尿酸干预对老年高血压合并糖尿病患者心功能的影响, 昆明医科大学学报.